Despite Changes In Benefit Plans, Retiring Scientists Still Have Options

Sidebar: For Further Information - Retiring Scientists Retirement, like many other facets of employment, has changed greatly over the last generation. Rare are the employees-researchers included-who spend 40 years at the same job and retire at age 65, living the remainder of their years off Social Security benefits and traditional company pensions. Instead, today's workers often switch jobs several times during the course of their careers, and when they retire, they are more likely to pay the

Written byThomas Durso
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Sidebar: For Further Information - Retiring Scientists

Instead, today's workers often switch jobs several times during the course of their careers, and when they retire, they are more likely to pay the bills with earnings from investments both they and their employers made. With the end of federally mandated retirement ages, first in government and private industry and most recently in academia, scientists are finding many ways to be productive well into their golden years.

It has now been two years since the mandatory retirement age of 70 for tenured faculty members was abolished (B. Goodman, The Scientist, April 18, 1994, page 1), which has allowed many researchers to continue teaching. Other schools, fearful of paying the higher salaries and benefits commanded by senior faculty members, now offer early-retirement packages that allow those scientists to keep working after stepping down as full-time employees.

ATTRACTIVE COMBINATION: Ken Marsi is retired, but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies